Symptomatic bradyarrhythmias in the athlete - underlying mechanisms and treatments.

Endurance exercise bradyarrhythmia electrophysiology pacemaking vagal tone

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 05 02 2023
revised: 02 02 2024
accepted: 07 02 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

Bradyarrhythmias including sinus bradycardia and atrioventricular (AV) block are frequently encountered in endurance athletes especially at night. While these are well tolerated by the young athlete, there is evidence that generally from the fifth decade of life onwards, such arrhythmias can degenerate into pathological symptomatic bradycardia requiring pacemaker therapy. For many years, athletic bradycardia and AV block have been attributed to high vagal tone, but work from our group has questioned this widely-held assumption and demonstrated a role for intrinsic electrophysiological remodelling of the sinus node and the AV node. In this article we argue that bradyarrhythmias in the veteran athlete arise from the cumulative effects of exercise training, the circadian rhythm and ageing on the electrical activity of the nodes. We consider contemporary strategies for the treatment of symptomatic bradyarrhythmias in athletes and highlight potential therapies resulting from our evolving mechanistic understanding of this phenomenon.

Identifiants

pubmed: 38428449
pii: S1547-5271(24)00222-4
doi: 10.1016/j.hrthm.2024.02.050
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : British Heart Foundation
ID : FS/19/1/34035
Pays : United Kingdom

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Sami Al-Othman (S)

Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.

Mark R Boyett (MR)

Faculty of Life Sciences, University of Bradford, Bradford, UK.

Gwilym M Morris (GM)

Cardiology Department, John Hunter Hospital, Newcastle, Australia.

Aneil Malhotra (A)

Institute of Sport, Manchester Metropolitan University and Manchester University NHS Foundation Trust, Manchester, UK.

Pietro Mesirca (P)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France;; Laboratory of Excellence In Ion Channel Science and Therapeutics (ICST), France.

Matteo E Mangoni (ME)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France;; Laboratory of Excellence In Ion Channel Science and Therapeutics (ICST), France.

Alicia D'Souza (A)

National Heart and Lung Institute, Imperial College London, UK.

Classifications MeSH